77 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 May 24
Maravai Lifesciences Reports First Quarter 2024 Financial Results
4:09pm
Quarter 2024
Three Months Ended March 31,
(Dollars in 000’s)
Year-over-Year % Change
Nucleic Acid Production
Biologics Safety Testing
Total Revenue … that did not repeat in the current quarter.
Biologics Safety Testing revenue was $18.2 million for the first quarter, representing a 3% increase year
8-K
EX-99.1
bqdv0b
22 Feb 24
Maravai Lifesciences Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
8-K
EX-99.1
g8bo8e sd
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
07i o33lzpgn0jlvuj
7 Aug 23
Maravai Lifesciences Reports Second Quarter 2023 Financial Results
4:19pm
8-K
z6971tx
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
8-K
EX-99.1
xaic9rgjtlz1 yk92
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
8-K
EX-99.1
7gdtc4ca
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
8-K
EX-99.1
gf7ufyfm
8 May 23
Maravai Lifesciences Reports First Quarter 2023 Financial Results
4:09pm
8-K
jzp6 2e2xddvly1ja
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm
8-K
EX-99.1
dai6hklh93dnqs79x
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm